Key result
Acute medical and endovascular therapies reduce infarct volume in acute ischaemic stroke.
Answers are grounded in this paper and cite their sources.
There are about 25.7 million stroke survivors worldwide. Ischaemic stroke remains the most common type of stroke. Numerous modifiable risk factors have been identified, including behaviors such as cigarette smoking and sedentary lifestyle and treatable medical comorbidities such as hypertension, hyperlipidemia and atrial fibrillation. Once considered irreversible, acute ischaemic stroke is now amenable to acute medical and endovascular therapies to reduce infarct volume. Many advances are expected in the years to come, particularly in the areas of prevention and recovery.
No takes yet. Share an insight, caveat, or question.
Meschia et al. (2017) conducted a review in Ischaemic stroke. Acute medical and endovascular therapies was evaluated on Infarct volume reduction. Acute medical and endovascular therapies reduce infarct volume in acute ischaemic stroke, which affects a global population with approximately 25.7 million stroke survivors.
Synapse has enriched 10 related papers. Consider them for comparative context: